These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 17096492)
1. Fat loss prompts SA treatment switch. IAPAC Mon; 2006 Jul; 12(7):212. PubMed ID: 17096492 [No Abstract] [Full Text] [Related]
2. On the trail of fugitive fat: the chase turns to NRTIs. Mascolini M J Int Assoc Physicians AIDS Care; 1999 Oct; 5(10):24-43. PubMed ID: 11366871 [TBL] [Abstract][Full Text] [Related]
3. Cohort studies: what do they tell us? Chêne G J HIV Ther; 2001 May; 6(2):28-31. PubMed ID: 11501200 [No Abstract] [Full Text] [Related]
4. Drug reactions & lipodystrophy workshop. Coppedge B STEP Perspect; 1999; 99(3):17-8. PubMed ID: 11366865 [TBL] [Abstract][Full Text] [Related]
5. Anti-HIV agents. Leading to lipodystrophy. TreatmentUpdate; 2007 Feb; 19(2):3-4. PubMed ID: 17447312 [No Abstract] [Full Text] [Related]
6. Longitudinal studies of the role of NRTIs in fat loss. Currier J AIDS Clin Care; 2002 Dec; 14(12):106-7. PubMed ID: 12510657 [No Abstract] [Full Text] [Related]
12. "Switch" studies for people with lipodystrophy. Proj Inf Perspect; 2000 Aug; (30):9. PubMed ID: 12171017 [TBL] [Abstract][Full Text] [Related]
13. Lipodystrophy and long-term therapy with nucleoside reverse transcriptase inhibitors. Moreno S; Martínez E AIDS; 2000 May; 14(7):905-6. PubMed ID: 10839605 [No Abstract] [Full Text] [Related]
14. Lipodystrophy associated with nevirapine-containing antiretroviral therapies. Aldeen T; Wells C; Hay P; Davidson F; Lau R AIDS; 1999 May; 13(7):865-7. PubMed ID: 10357391 [No Abstract] [Full Text] [Related]
15. [Lipodystrophy syndrome. After 3 years every third patient has lost his fat]. MMW Fortschr Med; 2000; 142(3 Suppl):16-7. PubMed ID: 11012290 [No Abstract] [Full Text] [Related]
16. Complications & side effects. Nukes and fat wasting. TreatmentUpdate; 2004; 16(7):3-4. PubMed ID: 17225282 [No Abstract] [Full Text] [Related]
17. HIV lipodystrophy: a review. Kravcik S HIV Clin Trials; 2000; 1(3):37-50. PubMed ID: 11590504 [TBL] [Abstract][Full Text] [Related]
18. The development of lipodystrophy on a protease inhibitor-sparing highly active antiretroviral therapy regimen. Leitz G; Robinson P AIDS; 2000 Mar; 14(4):468-9. PubMed ID: 10770555 [No Abstract] [Full Text] [Related]
19. Stavudine in antiretroviral therapy: is this the end? Brinkman K AIDS; 2009 Aug; 23(13):1727-9. PubMed ID: 19571724 [No Abstract] [Full Text] [Related]